Using liver tissue samples from patients with chronic hepatitis and cirrhosis caused by HCV infection, we previously demonstrated that CYGB is a unique marker of human HSCs that is negligibly expressed in portal myofibroblasts, which are positive for α-SMA, thy-1, and fibulin 2 [29]. Here, FBLN2 is linked to chronic hepatitis.